Compare · LYB vs MBII
LYB vs MBII
Side-by-side comparison of LyondellBasell Industries NV (LYB) and Marrone Bio Innovations Inc. (MBII): market cap, price performance, sector, and recent activity on the wire.
Summary
- LYB operates in Industrials, while MBII operates in Basic Industries - the two are in different parts of the market.
- LYB is the larger of the two at $21.73B, about 228.7x MBII ($95.0M).
- LYB has hit the wire 20 times in the past 4 weeks while MBII has been quiet.
- LYB has more recent analyst coverage (25 ratings vs 2 for MBII).
- Company
- LyondellBasell Industries NV
- Marrone Bio Innovations Inc.
- Price
- $67.31+0.01%
- $0.80-19.86%
- Market cap
- $21.73B
- $95.0M
- 1M return
- -11.45%
- -
- 1Y return
- +20.83%
- -
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2013
- News (4w)
- 20
- 0
- Recent ratings
- 25
- 2
LyondellBasell Industries NV
LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsÂAmericas; Olefins and PolyolefinsÂEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology. It produces and markets olefins and co-products; polyolefins; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; and polypropylene (PP) products, such as PP homopolymers and copolymers. The company also produces and sells propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomers, acetyls, ethylene glycols, and ethylene oxides and derivatives. In addition, it produces and markets compounds and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors, and powders; and advanced polymers. Further, the company refines crude oil and other crude oils of varied types and sources into gasoline, diesel, and jet fuel; develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts. LyondellBasell Industries N.V. was founded in 1955 and is headquartered in Houston, Texas.
Marrone Bio Innovations Inc.
Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Emergen, Foramin, Foramin ST, Pacesetter, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which are bio fungicides that protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. The company provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Davis, California.
Latest LYB
- SEC Form 4 filed by EVP & Chief Innovation Officer Seward James Malcolm
- SEC Form 4 filed by EVP, Sustainability & Corp Aff Campbell Tracey D
- LyondellBasell Industries NV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form SD filed by LyondellBasell Industries NV
- LyondellBasell upgraded by Wells Fargo with a new price target
- SEC Form S-8 filed by LyondellBasell Industries NV
- Director Griffin Rita E was granted 2,321 units of Class A Ordinary Shares and covered exercise/tax liability with 639 units of Class A Ordinary Shares, increasing direct ownership by 30% to 7,354 units (SEC Form 4) to cover taxes
- Director Manifold Albert Jude was granted 2,321 units of Class A Ordinary Shares and covered exercise/tax liability with 689 units of Class A Ordinary Shares, increasing direct ownership by 12% to 14,905 units (SEC Form 4) (for tax liability)
- Director Karlin Bridget E was granted 2,321 units of Class A Ordinary Shares and covered exercise/tax liability with 521 units of Class A Ordinary Shares, increasing direct ownership by 37% to 6,705 units (SEC Form 4) to satisfy withholding tax
- Director Kamsky Virginia A was granted 2,321 units of Class A Ordinary Shares and covered exercise/tax liability with 593 units of Class A Ordinary Shares, increasing direct ownership by 21% to 9,822 units (SEC Form 4) to satisfy withholding tax
Latest MBII
- ROTH MKM's Agribusiness Investment Banking Group Sees Success with the Closing of Three M&A Sellside Transactions
- Shares of chemicals companies are trading lower amid economic uncertainty following a bearish outlook from FedEx. An economic slowdown could weigh on end markets for chemicals and materials.
- SEC Form 15-12G filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form S-8 POS filed by Marrone Bio Innovations Inc.
- SEC Form S-8 POS filed by Marrone Bio Innovations Inc.